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         Nanoparticles of gold, which are in the size range of 10 to 100 nm, undergo a 
plasmon resonance with light. This is a process whereby the electrons of the gold 
resonate with incoming radiation causing them to both absorb and scatter light. The 
effect can be harnessed to either destroy tissue by local heating or release payload 
molecules of therapeutic importance. Gold nanoparticles  can also be conjugated with 
biologically-active moities, providing possibilities for targeting to particular tissues. 
Here we review progress in the exploitation of this plasmon resonance of gold 
nanoparticles in photo-thermal therapeutic medicine. 
 
Introduction 
Metallic gold, either in the form of bulk surfaces or as nanoparticles, is widely used in 
the emerging and highly interdisciplinary field of nanotechnology [1-3]. Many 
biodiagnostic applications of gold nanoparticles or electrodes have been developed 
since the 1970s [4-10].  However, the rational application of gold nanoparticles in 
therapeutic situations is a largely undeveloped field. Two properties of gold 
nanoparticles are attractive in this context. Firstly, antibodies and other biological 
molecules can be readily attached to the surface of gold nanoparticles, and secondly 
the plasmon resonances of gold nanoparticles of certain shapes cause them to have 
photon capture cross sections that are four to five orders of magnitude greater than 
those of photothermal dyes [11]. These attributes provide the possibility of obtaining 
very localized heating or drug release in a therapeutic application.  
 
Excellent reviews of the basic physical, chemical and optical properties of gold  
nanoparticles and their other applications are available [1, 12] and the medical uses of 
soluble gold compounds have been discussed by Shaw [13]. The medical applications 
of nanoparticles in general have been reviewed by Salata [14], while Moghimi et al. 
[15] have reviewed the use of nanoparticles in drug delivery schemes not involving 
light. Finally, the use of light to control drug delivery in liposomal systems was 
summarized by Shum [16]. However, while the medical applications of one kind of 
gold particle, the ‘nanoshell’ have been quite widely discussed recently [17-19], no 
broad synthesis of the recent developments in the photo-thermal, therapeutic 
possibilities of gold nanoparticles seems to exist in the literature at this time. This is 
the topic we address here, with only the most pertinent of the background information 
repeated.  
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Relevant properties of gold nanoparticles 
The reader is referred to Pyykko for a recent overview of the chemical physics of gold 
[20]. The aspects that are most relevant here are gold’s resistance to oxidation and its 
plasmon resonance with light. The latter is at ~520 nm for ordinary gold nanospheres, 
in the middle of the visible spectrum, but can be red-shifted into the near infrared 
(NIR, 800-1200 nm) for more complex shapes such as nanorods - see Box 1. This is 
useful because body tissue is reasonably transparent to NIR light [11, 17, 21], 
providing a window of sorts into the body by a number of methods. 
 
Gold or silver metallo-dielectric core-shell particles offer another route to spectral 
control of both absorption and scattering of light, particularly if the core is a dielectric  
(most commonly gold sulfide, silica or polystyrene) and the shell is a metal. The 
spectral properties of such shapes can be controlled by varying the relative 
dimensions of the core and shell [19, 22-27], Figure 1.  Several groups have reported 
successful recipes for the synthesis of these shapes, with the group of Halas at Rice 
University leading the way with a number of papers [9, 11, 17-19, 21, 27-33] and 
patents [34-38] on the manufacture and potential medical applications of these 
particles. Although the term ‘nanoshell’ is extant in North America for these particles, 
the term ‘core-shell particle’ is often used in Europe [39,40] for both metal-on-
dielectric, and dielectric-on-metal particles.   
 
Figure 1. The optical response of gold nano-shells at different sizes, showing how the extinction peak is 
red-shifted for relatively thinner shells (adapted and redrawn with permission from Loo, C. et al. 




Biomedical exploitation of gold nanoparticles 
 
Targeting strategies for  nanoparticles 
A disadvantage of many drug-based therapies (particularly when used orally or 
intravenously) is that the introduced compound is not localized to the target site, but is 
widely dispersed. Treatments based on nanoparticles can improve the situation. While 
the body can concentrate inert nanoparticles by ‘passive’ targeting, the therapeutic 
delivery system can enhanced  by functionalizing the surface of the gold particle so 
that it only targets specific tissues by ‘active’ targeting [15]. The two scenarios are 




Figure 2. Passive and active targeting of nanoparticles showing passive targeting of a tumor by 
extravasation (left) and active targeting of a carcinoma by an antibody-functionalized nanoparticle 
(right) (redrawn from McNeil [58] with permission). 
 
Passive targeting 
Nanoparticle colloids can be designed so that the particles are just big enough to be 
retained in the liver and spleen while passing relatively freely though other organs 
[15].  This type of passive targeting has been used in radiotherapy of liver cancers, 
since the sinus endothelium of that organ has openings of 150 nm in diameter, while 
the spleen filters out particles greater than 250 nm in size [15]. Similarly, the fact that 
the vasculature of tumors is somewhat more permeable that that of healthy issue [41] 
has also been exploited to concentrate nanoparticles. O’Neal et al reported that 
nanoshells with diameters of 130 nm would pass preferentially through the walls of 
vessels, and would be deposited and concentrated in the surrounding tumorous tissue 
[21].  This phenomenon of ‘extravasation’ provides another passive method to 
concentrate particles of up to 300 nm diameter  in some tumors or inflamed tissues 
[15].   
 
Active targeting 
Reliance upon retention of nanoparticles by size-specific filtration has obvious 
limitations. A more sophisticated approach is to functionalize the surface of the 
nanoparticle with an antibody or ligand for the desired target. Of course, this approach 
also has limitations due to non-specific binding and potential activation of the normal 
host immune response. The problem of an interaction between nanoparticle and 
immune system can be substantially alleviated by so-called ‘stealth’ technologies, 
which involve coating the nanoparticle with a self-assembled layer of a thiolated PEG 
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(poly-ethyleneglycol) [2,15,42]. The surfaces of such particles are reasonably inert 
with respect to protein absorption. Alternatively a liposome coating may have merit 
for the same reason. Of course, if a particle is so well coated that it becomes invisible 
to the immune system, then it will also probably lose its functionality in respect of 
binding to specific receptors.  
 
Once the gold nanoparticle is concentrated in the desired location, it can be activated 
by absorption of radiation of an appropriate wavelength. Broadly speaking, this action 
could be designed to deliver one of two therapeutic payloads; the localized generation 
of heat, or the localized release of a chemical. However, it may also be helpful to use 
the attached gold particles to simultaneously track or image the cells [9, 11].   
 
Hyperthermal therapy 
Local application of heat is a well-known concept in therapeutic medicine, and has 
been extensively explored for the treatment of cancer or other conditions. Energizing 
sources such as infrared lamps, ultrasound, or lasers can be used in the process, but 
there is always the problem of limiting the heat generated to the region of the target 
tissue [43]. As mentioned earlier, the problem can be solved in part by using gold 
nanoparticles tuned to absorb in the NIR such that the resulting localized heating 
causes irreversible thermal cellular destruction [18,19]. Although dyes can and have 
been used for this purpose, particles such as gold nanoshells have absorption 
efficiencies that are many orders of magnitude greater and that are not effected by 
photobleaching [18, 21]. Furthermore, as we have seen, there are ways to target 
nanoparticles that are simply not available for pharmaceutical compounds solubilised 
in vivo.  
 
The first account of the use of gold particles in hyperthermal therapy appeared in 
2003 [18, 36]. In this and follow-up work by the Halas group, gold-on-silica nano-
shells were used to actively target breast carcinoma cells by using the HER2 antibody  
[11], while extravasation was used to concentrate PEG-sheathed gold-on-silica 
nanoshells in an in vivo  murine model by passive targeting [21]. NIR irradiation was 
found in the latter study to raise the temperature of the target regions by 40 to 50ºC, 
which selectively destroyed the carcinomas. The survival rate of mice treated in this 
manner was excellent compared to controls. 
 
It is interesting to note, however, that the optical absorption spectrum of the gold 
particles used in the above work (for example, Figure 1 in reference [18]) had a very 
broad peak, and did not correspond to that of a particularly well-defined dispersion of 
nanoshells. Actually spectra of this type are also readily obtained with aggregated 
dispersions of solid gold nanospheres, cf. [44]. Not surprisingly therefore, the 
therapeutic effect can be obtained with particle morphologies other than nanoshells. 
This has been elegantly shown by Pitsillides et al,[45] who selectively destroyed 
CD8+ lymphocytes in a mixed CD8+/CD8- lymphocyte culture using ordinary 
colloidal gold nanoparticles. The particles were conjugated with a CD8+-specific 
antibody and used together with a 532 nm  laser, causing highly selective apoptosis of 
the CD8+ population.  In addition, systematic variation of the experimental technique 
revealed conditions that selectively permeabilized the cell membranes of the target 
population for up to two minutes, coupled with only a modest lethality. This provides 
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a unique and hitherto scarcely exploited therapeutic modality to access intracellular 
targets. 
 
  Finally, there is also an effect that causes enhanced absorption of X-ray radiation at 
the interface between materials of high and low atomic number. Although not an 
effect of plasmon resonance, the effect also causes a localized generation of heat and 
has the same net effect.  For example, the injection of 1.9 nm gold nanoparticles into 
murine tumors, followed by x-ray irradiation, caused tumor destruction [46]. In 
common with others [47], these workers found that the excess gold nanoparticles were 
cleared by the kidneys and that they were not toxic to the mice.  
 
Drug delivery 
        In this scenario the basic ideas are to encapsulate the payload inside a gold core-
shell particle, or to impregnate a larger drug-containing nano- or microparticle with 
suitably designed gold particles, or to bind the payload to the outer surface of a gold 
nanoparticle. Once at the target, release of the payload is induced by plasmonic 
heating.  In general, it is envisaged that the source of light would be a laser in order 
that the necessary precision of location and wavelength be achieved.  Gold 
nanoparticles themselves are sufficiently small that in principle they might be capable 
of delivering the payload of therapeutic agent or heat, directly into the cytoplasm or 
nucleus of the target cell [15,48,49].   
 
The first mention of photo-activated drug release by plasmonically active particles  
seems to have been in 2000 [17,27] followed by the appearance of a related US patent 
a little later [35]. In both cases the work exploited a polymer gel impregnated with 
gold nanoshells. These gold nanoshells were  gold-on-gold sulfide core-shell particles. 
This type of nanoshell was discovered by Zhou in 1994 [26] and so was not new, but 
the novelty was its incorporation into a polymer composite with the intention of 
securing controlled drug release.  
 
More recently, the plasmonic photo-activation of hollow polymer capsules containing 
model drugs has been demonstrated. First, Skirtach and colleagues described a 
scheme in which silver nanoparticles were incorporated into hollow polyelectrolyte 
capsules, which could then be burst by the light of a laser [50]. Evidently the effect of 
the illumination is to heat up the silver nanoparticles causing the polymer capsules to 
split and release their contents. Silver nanoparticles have a higher frequency plasmon 
resonance than gold particles, but the principles are otherwise the same. Soon after, 
Caruso and colleagues [51,52] used gold nanoparticles in a similar role. In this case, 
the illuminate-and-burst principle was successfully demonstrated by using a release of 
lysozyme to destroy the bacterium Micrococcus lysodeikticus. A schematic 
illustration of this latter scheme is shown in Figure 3. It was also shown that the 
capsules could be coated with a lipid bi-layer that was in turn functionalized with 




Figure 3.  Controlled delivery of a chemical payload  by a antibody-functionalized polymer capsule.  
Application of laser light causes the gold nanoparticles in the shell of the capsule to heat up, bursting 
the container (reproduced from Radt et al [62] with permission). 
 
A related idea is to bind the drug to the outside of a gold nanoparticle, using for 
example a light-sensitive and conformation-changing molecule such as spyropyran 
[53] to hold it in place. When spyropyran is irradiated by 320 nm light (in the low-
energy ultraviolet part of the spectrum) it undergoes a conformation change from an 
open form to a closed form. The open form can form complexes with amino acids, but 
these complexes are destroyed and the amino acid released when the change to the 
closed form occurs [53]. Gold is the ideal choice for the substrate particle, as it 
provides a convenient chemistry for attachment, but in this case the optical properties 
of gold are not directly exploited. Targeting of such particles is also by passive means 
only but, once again, further localization of the effect can be achieved with the light 
source. 
 
It has also been demonstrated that tumor necrosis factor (TNF) can be attached to gold 
nanoparticles and readily concentrated in murine tumors with beneficial results [47]. 
Once again, targeting is by extravasation  and essentially passive in nature.  No photo-
activation of the payload was invoked in this particular work but it is obvious that 
plasmonic heating of the gold particles, if it had been attempted, would very likely 
have exerted an influence on the outcome. 
 
An issue to be born in mind with these drug delivery schemes is that the volume of 
payload that can be carried by individual nanoparticles is very limited, and that in the 
absence of any external scheme to trigger release, the concentration of therapeutic 
agent released by gradual diffusion out, or breakdown of, the packaging might be too 
low to be effective [15]   
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Future developments 
Despite many advances in the field, there is a still a significant requirement for new 
technologies that will allow for the earlier treatment of diseases such as cancer, 
particularly if they also offer greater specificity and cost-effectiveness. It can be 
expected that continued development of the techniques described above will take 
place, particularly in respect of active targeting. Also, it is probable that the chemical 
and physical-based therapies reviewed above will be complemented by gene therapies 
delivered by nanoparticles.  
 
It is apparent that gold nanoparticles have unique chemical and physical properties 
that facilitate and commend their use in these applications, despite some questions 
that remain unanswered (Box 2). In particular, their tunable optical properties and 
flexible surface chemistry suggest their use in photo-thermal therapeutic treatments. 
As discussed, the efficiencies of the process can be considerably enhanced by 
exploiting various passive targeting strategies to concentrate the nanoparticles in the 
tissue to be treated. In principle, active targeting of the nanoparticle is also possible, 
although further work on methods to evade the immune system en route to the target 
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Optical properties of metal nanoparticles 
 
A nanoscale electronic effect known as the plasmon resonance causes metallic 
nanoparticles to absorb and scatter electromagnetic radiation of wavelengths 
considerably larger than the particles themselves.  These effects are particularly 
obvious in the visible part of the spectrum for gold, silver and copper. In the case 
of gold nanospheres the ‘plasmon’ resonance, and hence absorption, is at around 
520 nm (corresponding to green light). In fact, a proportion of the incident light is 
also scattered, but it is the light that is absorbed that will cause heating in the 
particles. This results in a highly localized increase of temperature that is exploited 
in the various proposed photo-thermal therapeutic uses of gold nanoparticles. 
Further background information on the optical phenomena involved may be found 
in a standard text, such as that of Bohren and Huffman  [54].  
 
It may be convenient to shift the wavelength of maximum absorption into the near 
infrared because the body is more transparent at those wavelengths [11, 21]. This 
may be achieved with gold nanoshells [17], or by enhancing the dipole-dipole 
interaction between aggregated gold nanospheres [44, 55, 56], or by decreasing the 
symmetry of the particles to form, for example nanorods [57]. Gold nanorods have 
two plasmon absorption peaks, and the position of the second peak can be moved 
deep into the NIR by controlling the aspect ratio of the rod. Gold ’nano-caps’ [58] 

















Although most available evidence suggests that colloidal gold particles are 
chemically inert in vivo, the issue is not definitively settled and requires proper, 
controlled study. Certainly, it is known that such particles will be ingested by cells 
of the immune system unless rendered ‘invisible’ by one of the so-called ‘stealth’ 
technologies, and the overall implications of this need to be considered. Of course 
removal of particles from the vasculature by leukocytes is especially problematic  
in respect of actively-targeted nanoparticles, which by definition need to expose 
some antigenic structure on their exteriors.  Perhaps there will be a short period of 
opportunity available to such particles to be delivered to their target sites before the 
patient’s immune system can mount a full reaction. Finally, one of the most 
interesting challenges is whether it will be feasible to actively target intra-cellular 
pathogens using functionalized nanoparticles, since the antigenic properties of 
these are usually well concealed.  
 
